Aehr Test Systems is recognized for its strong technology and leading role in AI chip burn-in testing, backed by a robust order book. However, its stock trades at a high valuation of 35 times projected 2027 revenue, exceeding industry peers and leaving little margin for error. Despite record bookings and positive demand, the company faces revenue declines and margin compression over two consecutive years. The recommendation is to hold the stock, with current investors advised to take profits and new investors to consider buying only if prices drop to the mid-$60 range to balance risk and reward.
Aehr Test Systems, Inc. is initiated with a Buy rating and a $144 price target, suggesting a 50% upside from the current $96 price. The key growth driver is AI burn-in, supported by a $41 million order from a hyperscale customer, indicating the compa...
Aehr Test Systems is shifting its semiconductor testing business towards AI processors and data centers, driving strong growth prospects. The company reported $18.8 million in Q4 revenue, up from $14.1 million last year, and a net income turnaround t...
Aehr Test Systems reported better-than-expected fiscal Q4 results with adjusted earnings of $0.11 per share and revenue of $18.8 million, beating estimates. The company also posted record bookings of $60.7 million and a backlog of $80.6 million, sign...
Aehr Test Systems reported a strong quarterly performance with earnings per share of $0.11, reversing a loss from the previous year and beating analyst expectations. The company posted revenue of $18.80 million, surpassing estimates and showing signi...
Aehr Test Systems reported record quarterly bookings of $60.7 million and an effective backlog of $100.6 million for fiscal 2026 Q4, driving strong visibility for fiscal 2027 revenue projected between $130 million and $150 million, a 160-200% increas...
